Literature DB >> 17515452

Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction.

Céline Bouvet1, Eric Belin de Chantemèle, Anne-Laure Guihot, Emilie Vessières, Arnaud Bocquet, Odile Dumont, Alain Jardel, Laurent Loufrani, Pierre Moreau, Daniel Henrion.   

Abstract

Chronic increases in blood flow increase arterial diameter and NO-dependent dilation in resistance arteries. Because endothelial dysfunction accompanies metabolic syndrome, we hypothesized that flow-mediated remodeling might be impaired in obese rat resistance arteries. Obese and lean Zucker rat mesenteric resistance arteries were exposed to chronic flow increases through arterial ligation in vivo: arteries exposed to high flow were compared with normal flow arteries. Diameter was measured in vitro in cannulated arteries using pressure arteriography. After 7 days, outward remodeling (diameter increased from 346+/-9 to 412+/-11 mum at 100 mm Hg) occurred in lean high-flow arteries. Endothelium-dependent tone was reduced in high-flow arteries from obese rats by contrast with lean animals. On the other hand, diameter enlargement occurred similarly in the 2 strains. The involvement of NO in endothelium-dependent dilation (evidenced by NO blockade) and endothelial NO synthase phosphorylation was smaller in obese than in lean rats. Superoxide anion and reduced nicotinamide-adenine dinucleotide phosphate oxidase subunit expression (p67phox and gp91phox) increased in obese rats and were higher in high-flow than in control arteries. Acute Tempol (a catalase mimetic), catalase plus superoxide dismutase, and l-arginine plus tetrahydrobiopterin restored endothelium-dependent dilation in obese rat normal and high-flow arteries to the level found in lean control arteries. Thus, flow-induced remodeling in obese resistance arteries was associated with a reduced endothelium-mediated dilation because of a decreased NO bioavailability and an excessive superoxide production. This dysfunction might have negative consequences in ischemic diseases in patients with obesity or metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515452     DOI: 10.1161/HYPERTENSIONAHA.107.088716

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  28 in total

1.  Role of the cytoskeleton in flow (shear stress)-induced dilation and remodeling in resistance arteries.

Authors:  Laurent Loufrani; Daniel Henrion
Journal:  Med Biol Eng Comput       Date:  2008-05       Impact factor: 2.602

Review 2.  Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation.

Authors:  Eric J Belin de Chantemele; David W Stepp
Journal:  J Mol Cell Cardiol       Date:  2011-08-26       Impact factor: 5.000

3.  Spatial heterogeneity in skeletal muscle microvascular blood flow distribution is increased in the metabolic syndrome.

Authors:  Jefferson C Frisbee; Fan Wu; Adam G Goodwill; Joshua T Butcher; Daniel A Beard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-07-20       Impact factor: 3.619

Review 4.  Microvascular perfusion heterogeneity contributes to peripheral vascular disease in metabolic syndrome.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Stephanie J Frisbee; Joshua T Butcher; Fan Wu; Paul D Chantler
Journal:  J Physiol       Date:  2014-12-18       Impact factor: 5.182

5.  Divergence between arterial perfusion and fatigue resistance in skeletal muscle in the metabolic syndrome.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Joshua T Butcher; I Mark Olfert
Journal:  Exp Physiol       Date:  2010-12-01       Impact factor: 2.969

6.  Reactive oxygen species cause endothelial dysfunction in chronic flow overload.

Authors:  X Lu; X Guo; C D Wassall; M D Kemple; J L Unthank; G S Kassab
Journal:  J Appl Physiol (1985)       Date:  2010-12-02

7.  TNF-α impairs endothelial function in adipose tissue resistance arteries of mice with diet-induced obesity.

Authors:  Anthony J Donato; Grant D Henson; R Garrett Morgan; Ryley A Enz; Ashley E Walker; Lisa A Lesniewski
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-20       Impact factor: 4.733

Review 8.  Cardiac NO signalling in the metabolic syndrome.

Authors:  O Pechánová; Z V Varga; M Cebová; Z Giricz; P Pacher; P Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

9.  Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension.

Authors:  Adam G Goodwill; Milinda E James; Jefferson C Frisbee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-08       Impact factor: 4.733

10.  Differential effects of diet-induced dyslipidemia and hyperglycemia on mesenteric resistance artery structure and function in type 2 diabetes.

Authors:  Kamakshi Sachidanandam; Jim R Hutchinson; Mostafa M Elgebaly; Erin M Mezzetti; Mong-Heng Wang; Adviye Ergul
Journal:  J Pharmacol Exp Ther       Date:  2008-10-21       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.